BioCentrum's mission is to create a platform for its clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to reach the market, in the shortest amount of time possible.
Since 2008, BioCentrum is a part of the Selvita Group.
Preclinical researchBioCentrum is active in several areas of life science and offers custom services ranging from in vitro preclinical development services and assay development, through specialized services in analytical and physicochemical chemistry, as well as services in the field of protein chemistry.
BioCentrum's laboratories have the General Pharmaceutical Inspectorate accreditation and Good Laboratory Practice (GLP) certification.
ProductsBioCentrum also specializes in production of highly purified and highly active enzymes, inhibitors and other biologically active recombinant proteins.